Clinical trials
Trials in Serbia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,862 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 8 |
| 2004 | 21 |
| 2005 | 22 |
| 2006 | 44 |
| 2007 | 57 |
| 2008 | 79 |
| 2009 | 66 |
| 2010 | 62 |
| 2011 | 88 |
| 2012 | 71 |
| 2013 | 78 |
| 2014 | 79 |
| 2015 | 97 |
| 2016 | 111 |
| 2017 | 96 |
| 2018 | 97 |
| 2019 | 106 |
| 2020 | 87 |
| 2021 | 106 |
| 2022 | 88 |
| 2023 | 92 |
| 2024 | 127 |
| 2025 | 94 |
| 2026 | 60 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,150 |
| Recruiting | 214 |
| Terminated | 199 |
| Active, not recruiting | 164 |
| Unknown status | 87 |
| Enrolling by invitation | 22 |
| Withdrawn | 9 |
| Not yet recruiting | 8 |
| No longer available | 5 |
| Suspended | 3 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 109 |
| Novo Nordisk A/S | 78 |
| University of Belgrade | 70 |
| Pfizer | 58 |
| AbbVie | 46 |
| AstraZeneca | 41 |
| Boehringer Ingelheim | 33 |
| Sanofi | 32 |
| Novartis Pharmaceuticals | 26 |
| Takeda | 26 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 82 |
| Arthritis, Rheumatoid | 78 |
| Diabetes Mellitus, Type 2 | 65 |
| Crohn Disease | 52 |
| Schizophrenia | 49 |
| Carcinoma, Non-Small-Cell Lung | 48 |
| Breast Neoplasms | 46 |
| Heart Failure | 43 |
| Multiple Sclerosis | 40 |
| Diabetes Mellitus | 39 |
Trials
Showing 1 to 25 of 1,862. Each trial links to its page on Pharma Observatory.
1,762 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.